Related Experiment Video
Updated: Jul 4, 2025

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Intramyocardial Hemorrhage Leads to Higher MACE Rate by Increasing Myocardial Infarction Volume in Patients with
Zhijian Wu1,2,3, Xiaotian Jin1, Ilyas Tudahun1
1Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, 410011, People's Republic of China.
Insights
Intramyocardial hemorrhage (IMH) in ST-elevation myocardial infarction (STEMI) patients increases myocardial infarction (MI) volume and lowers ejection fraction. This leads to a higher major adverse cardiovascular event (MACE) rate after reperfusion therapy.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Interventional Cardiology
Background:
- The direct impact of intramyocardial hemorrhage (IMH) on persistent myocardial necrosis following reperfusion therapy in ST-elevation myocardial infarction (STEMI) patients remains unclear.
- Investigating the correlation between IMH and adverse cardiovascular outcomes is crucial for STEMI patient management.
Purpose of the Study:
- To compare cardiovascular parameters in STEMI patients with and without IMH.
- To explore the potential relationship between IMH and poor cardiovascular outcomes after primary percutaneous coronary intervention (PCI).
Main Methods:
- A prospective study enrolled 65 STEMI patients undergoing primary PCI.
- Patients were categorized into IMH-absent (n=38) and IMH-present (n=27) groups.
- Cardiovascular parameters, including myocardial infarction (MI) volume (LGE-CMR), hs-TNT levels, LVEF (CMR), and Major Adverse Cardiovascular Events (MACE), were assessed post-reperfusion and at 12-month follow-up.
Main Results:
- STEMI patients with IMH exhibited significantly larger MI volumes (34.2 ± 12.7 cm³ vs 21.1 ± 13.1 cm³, P<0.001) compared to those without IMH.
- The IMH-present group showed higher hs-TNT levels (P=0.021) and lower LVEF (30.7 ± 9.8% vs 42.3 ± 11.0%, P<0.001).
- A significantly higher MACE rate at 12 months was observed in the IMH-present group (9/27 vs 2/38, P=0.012).
Conclusions:
- Intramyocardial hemorrhage (IMH) is associated with increased myocardial infarction (MI) volume in STEMI patients.
- IMH contributes to reduced left ventricular ejection fraction (LVEF) and a higher incidence of major adverse cardiovascular events (MACE) post-discharge.
- IMH is a significant predictor of poor outcomes in STEMI patients treated with primary PCI.
Background And Aims:
Whether IMH can directly cause persistent myocardial necrosis after reperfusion therapy in STEMI patients is still unclear. We conducted a prospective study to compare the cardiovascular parameters in patients with STEMI with and without IMH to explore the potential correlations between IMH and poor outcomes.
Methods And Results:
We prospectively enrolled 65 consecutive patients with newly diagnosed STEMI admitted to the CCU of the Second Xiangya Hospital of Central South University between April 2019 and November 2021, all of whom underwent primary PCI. Of these, 38 (58.5%) and 27 (41.5%) patients were in the IMH-absent and IMH-present groups, respectively. At a mean time of 5-7 days after reperfusion therapy, the volume of MI measured using LGE sequence was larger in STEMI patients with IMH than in patients without IMH (34.2 ± 12.7 cm3 vs 21.1 ± 13.1 cm3, P<0.001). HsTNT levels were significantly higher in the IMH-present group than in the IMH-absent [2500.0 (1681.5-4307.0) pg/mL vs 1710.0 (203.0-3363.5) pg/mL, P=0.021] group during hospitalization. The LVEF measured using CMR in the IMH-present group was lower than that in the IMH-absent group (30.7 ± 9.8% vs 42.3 ± 11.0%, P < 0.001). The rate of MACE at 12 months in IMH-present group was significantly higher than in the IMH-absent group (9/27 VS 2/38, P = 0.012).
Conclusion:
IMH can lead to further expansion of MI volumes in patients with STEMI, resulting in lower LVEF and higher MACE rate in the post-discharge follow-up.
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiac Output and Stroke Volume
In an average resting adult male, the typical cardiac...

